Latest stories on CORT
Corcept targets $1.1B-$1.2B 2026 revenue as Lifyorli launch reaches 1,300 patients and relacorilant awaits Dec. 17 PDUFA
Seeking Alpha73 · bullishearnings
Corcept Therapeutics Incorporated (CORT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
CORCEPT THERAPEUTICS INC (CORT) files 8-K
SEC 8-K50 · neutralgeneral
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update | CORT Stock News
StockTitan50 · neutralgeneral
Wolfe Research downgrades Corcept stock on valuation concerns
Investing.com Analyst Ratings38 · neutralanalyst
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know
The Motley Fool38 · neutralgeneral
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound
The Motley Fool56 · neutralgeneral
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook
Yahoo Top48 · neutralgeneral
Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook
The Motley Fool48 · neutralgeneral
Corcept Therapeutics: Recent Relacorilant Rejection Aside, A Good News Story For Investors
Seeking Alpha67 · bullishanalyst
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm
PR Newswire34 · bearishgeneral
Corcept Resubmits FDA Application for Relacorilant in Cushing’s
TipRanks63 · neutralproduct/pr
Corcept Resubmits FDA Application for Cushing Syndrome Drug
Morningstar56 · neutralproduct/pr
Corcept resubmits relacorilant NDA for Cushing’s syndrome
Seeking Alpha58 · neutralproduct/pr
CORCEPT THERAPEUTICS INC (CORT) files 8-K
SEC 8-K50 · neutralgeneral
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome | CORT Stock News
StockTitan56 · neutralproduct/pr
Catalyst and Momentum Trials Data Fuels Optimism for Corcept Therapeutics (CORT)
Yahoo Finance73 · bullishproduct/pr
Corcept stockholders approve expanded incentive plan and board
TipRanks55 · neutralgeneral
CORT: [144] CORCEPT THERAPEUTICS INC SEC Filing
StockTitan SEC50 · neutralgeneral